Boots reports 4.5% rise in full-year EBITDA
In the year to 31 March 2013, the group increased its trading profit by 6.1% to £1.27 billion despite revenues falling by 2.6% to £22.4 billion.
The group’s trading profits at its health and beauty division grew 8.6% to £865 million while its pharmaceutical wholesale division saw growth of 5.1% to £435 million.
During the year, the group entered a strategic partnership with Walgreens to create the first global pharmacy-led, health and well-being enterprise.
Stefano Pessina, executive chairman, said: "This has been a transformational year for Alliance Boots due to our exciting new strategic partnership with Walgreens, which we are further strengthening by our recent joint agreement to partner with AmerisourceBergen.
"Against the backdrop of this major corporate activity, and the challenging conditions across our markets, we have again delivered a double digit growth in underlying profit after tax. Our people are at the heart of everything we do and it is through clear leadership combined with great teamwork that we have been able to deliver such consistently good results.
"We continue to be confident about our prospects and ability to pursue profitable growth, organically, from our synergy programmes and through international expansion."
Email this article to a friend
You need to be logged in to use this feature.
Please log in here